Background & Aims Cirrhosis and age (CAGE-B) and stiffness and age (SAGE-B) models
assess the risk of hepatocellular carcinoma (HCC) development in white patients with
chronic hepatitis B (CHB) undergoing sustained antiviral therapy (AVT). Herein, we checked
the predictive performance of these models in Asian patients with CHB. Methods We
reviewed 734 treatment-naive patients with CHB who started entecavir between 2006 and
2011 and were followed up for more than 5 years without HCC development during AVT …

Aims: Recently, CAGE-B and SAGE-B models were used to assess the risk of developing
hepatocellular carcinoma (HCC) in Caucasian patients with chronic hepatitis B (CHB) under
sustained antiviral therapy (AVT). We checked the predictive performance of these models in
Asian patients with CHB. Methods: We reviewed 737 treatment-naïve patients with CHB who
started entecavir between 2006 and 2011, and who were followed up for more than 5 years
without HCC development within 5 years of AVT. The predictive performance of CAGE-B …